AI tool tested in heart procedure: does it improve outcomes?

NCT ID NCT06083012

Ongoing Knowledge-focused Sponsor: Volta Medical Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated May 04, 2026 · Updated 8 times

Summary

This study follows 186 adults in Europe undergoing a heart procedure (catheter ablation) for atrial fibrillation, using an AI software to guide treatment. The goal is to see how well the AI works in everyday practice, including safety, long-term heart rhythm control, and healthcare costs. Participants are observed for up to 24 months, with no changes to their normal care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Centre Cardiologique du Nord

Saint-Denis, 93207, France
Clinique Pasteur

Toulouse, 31000, France
Clinique Rhéna

Strasbourg, 67000, France
German Heart Center Munich

München, 80636, Germany
Hôpital Privé Jacques Cartier

Massy, 91300, France
Hôpital Saint-Joseph

Marseille, 13008, France
Polyclinique Saint George

Nice, 06105, France

Conditions

Explore the condition pages connected to this study.

ARRHYTHMIAS, CARDIAC ARRHYTHMIAS, CARDIAC ATRIAL ARRHYTHMIA ATRIAL FIBRILLATION